These findings not only explore more intricate mechanisms of the two miRNAs (miR-4487 and miR-595) targeting ULK1 in SH-SY5Y cells, but provide new autophagy-related biomarkers of miRNAs for potential PD therapy. This evidence concerns the gene ULK1 and Parkinson disease.